Form 4: Bicycle Therapeutics' Chief Scientific Officer Sells Shares to Cover Tax Obligations

Nicholas Keen, Chief Scientific Officer of Bicycle Therapeutics plc, sold 790 ordinary shares on April 3, 2024, to cover tax withholding obligations related to the vesting and settlement of Restricted Stock Units (RSUs).

Summary

• Nicholas Keen, the Chief Scientific Officer of Bicycle Therapeutics plc, reported a transaction involving the sale of company shares.
• On April 3, 2024, Keen sold 790 ordinary shares at a weighted average price ranging from $23.75 to $24.05, with an average of $23.81.
• The sale was executed to cover statutory tax withholding obligations associated with the vesting and settlement of RSUs.
• Following the transaction, Keen directly owns 62,803 ordinary shares and indirectly owns 7,000 shares through a GRAT (Grantor Retained Annuity Trust).

Sentiment

Score: 6

Explanation: The document reflects a routine transaction (sale of shares to cover taxes) and doesn't indicate any significant positive or negative sentiment regarding the company's performance or future prospects.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and employees.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates